Skip to main content
. 2022 May 4;327(19):1899–1909. doi: 10.1001/jama.2022.4798

Table 2. Primary and Secondary Outcome Results.

Tracheostomy, No./total (%) Absolute difference, % (95% CI) Effect measure (95% CI)
Early (n =186) Standard (n = 194)
Primary outcome, 6 mo
Modified Rankin Scale score, 0-4a 77/177 (43.5) 89/189 (47.1) −3.6 (−14.3 to 7.2) aOR, 0.93 (0.60 to 1.42)b,c,d
Secondary outcomes
Modified Rankin Scale score, 0-3 at 6 moa 43/177 (24.3) 37/189 (19.6) 4.7 (−4.3 to 13.7) aOR, 1.48 (0.89 to 2.48)b,c
Death
at 6 mo 62/177 (35.0) 56/189 (29.6) 5.4 (−4.7 to 15.5) aHR, 1.06 (0.74 to 1.53)b,e
in ICUf 26/186 (14.0) 29/194 (14.9) −1.0 (−8.6 to 6.6)
Due to withdrawal of life-sustaining therapy 24/186 (12.9) 21/194 (10.8) 2.1 (−5.0 to 9.1)
Time to discharge, dg
ICU, median (IQR) 17 (12 to 26) 19 (14 to 26) HR, 1.12 (0.90 to 1.39)
Hospital 24 (15 to 41) 26 (17 to 44) HR, 1.06 (0.85 to 1.32)
Discharge destination
Home 1/144 (0.7) 5/156 (3.2)
Rehabilitation center 101/144 (70.1) 110/156 (70.5)
Long-term care facility 26/144 (18.1) 25/156 (16.0)
Otherh 16/144 (11.1) 16/156 (10.3)
Location of survivors at 6 mo
Home 54/115 (47.0) 65/133 (48.9)
Hospital 6/115 (5.2) 2/133 (1.5)
Rehabilitation center 29/115 (25.2) 29/133 (21.8)
Long-term care facility 23/115 (20.0) 36/133 (27.1)
Otheri 3/115 (2.6) 1/133 (0.8)
Respirator weaning started 138/186 (74.2) 130/194 (67.0) 7.2 (−2.5 to 16.8)
Time to start weaning, dj 6 (4 to 11) 6 (3 to 13) HR, 1.24 (0.98 to 1.58)
Successful weaningk 87/186 (46.8) 91/194 (46.9) −0.1 (−10.7 to 10.4)
Time to end mechanical ventilation, median (IQR), dj 14 (8 to 20) 11 (8 to 18) HR, 0.97 (0.73 to 1.31)
Extubation attempts
At least 1 18/186 (9.7) 75/194 (38.7)
More than 1 4/186 (2.2) 21/194 (10.8)
First attempt successfull 2/18 (11.1) 35/75 (46.7)
Extubated after weaningl 3/18 (16.7) 43/75 (57.3)
Recovery of consciousnessm 100/141 (70.9) 97/144 (67.4) 3.6 (−7.9 to 15.0)
Time to first day out of coma, median (IQR), dj 4 (1.5 to 7.5) 5 (2 to 10) HR, 1.15 (0.87 to 1.52)
ICU stay, median (IQR), dm
Without sedatives 9 (5 to 14) 9 (3 to 15) HL, 0 (−1 to 2)
Without opioids 8 (1 to 14) 8 (1 to 14) HL, 0 (−2 to 1)
Without vasopressors 11 (6 to 16) 12 (4.5 to 17) HL, 0 (−1 to 2)
Fraction of total days in ICU, median (IQR)m
Without sedatives 0.6 (0.3 to 0.8) 0.5 (0.2 to 0.8) HL, 0.02 (−0.04 to 0.1)
Without opioids 0.5 (0.1 to 0.8) 0.5 (0.1 to 0.8) HL, 0 (−0.08 to 0.04)
Without vasopressors 0.8 (0.4 to 1) 0.8 (0.3 to 1) HL, 0 (0 to 0.07)

Abbreviations: aHR, adjusted hazard ratio; aOR, adjusted odds ratio; GCS, Glasgow Coma Scale; HL, Hodges-Lehmann estimate; ICU, intensive care unit; mRS, modified Rankin Scale.

a

See Table 1 footnotes for score definitions.

b

Adjusted for age, baseline GCS, and country.

c

Used multiple imputation to replace missing values.

d

P = .73 for the primary end point. See eTable 2 in Supplement 3 for other variables.

e

Patients lost to follow-up were censored: 1 patient was excluded from this Cox regression due to missing GCS status at baseline.

f

Therapy withdrawals during ICU were counted as ICU deaths.

g

Median (IQR) by Kaplan-Meier method. Patients who died during ICU or hospital stay were censored after the last patient was discharged.

h

Other destinations: acute care hospital, palliative care facility, hospice, skilled nursing, and step-down unit.

i

Other locations: monastery, assisted living, skilled nursing, and nursing home.

j

Median (IQR) for patients who reached the end point. HR from a Cox proportional hazards model for which deaths before reaching the end point were censored after the last event in the cohort.

k

End of mechanical ventilation the same day as death or treatment withdrawal were not counted; 94 more decannulations noted in the follow-up (early tracheostomy, 41; standard tracheostomy, 54).

l

Nonterminal extubations not leading to reintubation or tracheotomy are counted as successful.

m

Fewer patients because variables were added after a protocol amendment (early group, 141; standard group, 144).